FT. WASHINGTON, Pa. (PRWEB)
April 16, 2020

HGE Health has reached an agreement with Adherium to integrate Adherium’s medication compliance sensor technology into HGE Health’s digital patient management platform. The HGE Health platform currently takes into consideration a patient’s symptoms to determine whether that patient’s condition is worsening, or is expected for the current state of their COPD. Integration of Adherium’s Hailie™ sensor will allow the contribution of each patient’s adherence, or lack thereof, to an inhaled prescription drug regimen to be considered in evaluating the patient’s condition for worsening trends.

HGE Health’s digital platform and technology-enabled services, called HGE Care, allows pulmonary and primary care physicians to remotely care for patients from anywhere in the nation, and help patients better understand and manage changes in their COPD symptoms. Thanks to daily digital interaction with their healthcare team, patients are engaged in their own symptom management, and log their symptoms on the HGE Care platform over 80% – 90% of the time. In the background, Adherium’s integrated medication compliance sensor detects the frequency and quantity of an inhaled drug taken by the patient to be included in the symptom logs.

“The symptoms of patients enrolled on our digital platform may become more severe not because their current medical condition has worsened, but because they have failed to take their medications as prescribed,” explained Michael J. Markus, PhD, the CEO of HGE Health. “Our clinically-validated algorithms may recommend prescribing a higher dose of a recovery medication or other drug than was previously prescribed, but the higher dose may be unnecessary if the patient complies with the original prescription. Knowing whether patients are in compliance with their prescriptions will also allow the effectiveness of different medications to be evaluated on a patient by patient basis. This new ability to monitor and consider medication adherence is appealing to our existing customers and partners.”

“For example, Respircare in Tulsa, Oklahoma will be one of the first in the country to utilize the Hailie™ sensor with HGE technology. This new capability is already expanding Respircare’s relationships with local payors and native American tribes for COPD and asthma management in Oklahoma,” explained Dr. Mark Boomer, MD, CEO of Respircare. “Patients enjoy peace of mind that each day they experience a change from their typical COPD symptoms, their own physician/care team will provide same-day feedback, occasionally involving no more than an instruction to take a medication, as prescribed. As a result, patients breathe easier, avoid ER and hospital admissions, and enjoy an improved quality of life, all while reducing overall healthcare costs for patients and their health plans.”

“Adherium’s Hailie™ sensor was initially developed to monitor when, and how often asthma patients used their rescue inhaler,” explained Mike Motion , COO of Adherium. “The sensor technology is very adaptable, and is compatible with the majority of inhalers used in asthma treatment today and is well suited to monitor medication compliance across a wide variety of chronic illnesses, including COPD, that are effectively treated with inhaled medications.”

It is this adaptability to a variety of chronic illnesses that HGE Health plans to leverage for one of its many expansions outside of COPD planned for 2020. HGE Health, currently the market leader and only full-service remote patient management solution in the COPD space, will now expand its offerings to new and existing customers for remote asthma management as part of this alliance with Adherium. The Adherium collaboration with HGE Health provides an option available to HGE Health’s substantial customer base of payers and healthcare providers.

Based in Fort Washington, Pennsylvania, HGE Health has built an international reputation in the field of COPD and pulmonary medicine, helping COPD, lung transplant and other respiratory patients and physicians control pulmonary issues. With over a decade of experience remotely monitoring COPD patients and facilitating early clinical interventions, HGE Health has observed patients experiencing fewer severe symptoms and a general improvement in the quality of life.

Adherium has become a global leader in medication compliance technology by developing multiple FDA approved medical devices. Adherium’s technology has been used in clinical studies resulting in more than 80 peer-reviewed papers. The developments were motivated by the realization that more than 50% of patients suffering chronic illness do not take their medications as prescribed, leading to poor patient outcomes, disease progression, and an estimated burden of $100-300 billion annually in avoidable direct healthcare costs in the US alone, and a $564 billion burden globally. The resulting monitoring technology uses wireless communications technology to provide real-time data collection and reporting from Adherium’s Hailie™ sensors.

About HGE Health

Headquartered in Fort Washington, PA, HGE Health harnesses its deep experience in chronic disease management and digital health in pulmonary disease, telemedicine, and mobile health to develop a clinical services platform that delivers better care faster at a much lower cost for patients, physicians and payors. Built on clinical protocols developed and supported by 16 years of research, the company’s technology has compiled the longest-running and world’s largest longitudinal data set of COPD symptoms, interventions, and clinical management to help physicians provide care for a geographically and socio-economically diverse COPD and pulmonary patient population.

About Adherium

Adherium is a global leader in digital health technologies which address sub-optimal medication use in chronic disease. Among those technologies is the Hailie™ sensor technology, which attaches to prescription inhalers to provide reminders and to monitor inhaler usage. Independent studies have shown that the Hailie™ sensors improve medication adherence and health outcomes for patients with chronic respiratory disease.

About RespirCare

Founded in Tulsa, OK, RespirCare is a novel clinic dedicated to treating acute and chronic respiratory conditions, from minor to the most severe. Remote symptom monitoring is offered to allow clinical interventions to be performed immediately, as symptoms begin to worsen. Treatment is available at RespirCare by appointment and as a walk-in clinic, which is open 7 days a week to ensure immediate care is available when patients need it most. A separate waiting room available for contagious patients, and oxygen outlets throughout establishes a patient-centric waiting environment with patient wellbeing and comfort in mind. RespirCare offers regular and after-hours care for no more than the cost of a visit to your regular pulmonary specialist, avoiding the costs of an emergency department visit.

Share article on social media or email:

BETHESDA, Md. (PRWEB)
April 16, 2020

People prefer interacting before availing any service, especially when its healthcare. Trust regarding the genuineness of products, reports, and service is what they look forward to and so they prefer directing dialing in the contact center. Here, an agent merely transferring a call to the concerned department might not be very helpful as no one wants to hold the call and discuss issues repeatedly. Healthcare contact centers need a solution to equip agents with technology that help them create personalized caller experience. This is where NovelVox EPIC connector can do wonders for your healthcare business. NovelVox has been serving call center industry for the past 11 years and has designed solutions focusing on various business verticals or industries. EPIC CTI connector is one for the healthcare industry to empower agents to deal with issues of booking or confirming appointments, scrambling between applications for information gathering and more.

NovelVox has embedded a CTI connector in Hyperspace. Agent logs into Hyperspace application that has CTI call controls and agent state control. NovelVox connector pops out the page with caller information and agent accepts call within Hyperspace to avoid any page switching. The connector is loaded with features such as click-to-dial, call transfer, contact search, automatic customer record retrieval, etc. It empowers Cisco, Avaya, Genesys contact center agents to improve resolution and lower average handle time with more patient satisfaction.

Amit Gandhi, CEO NovelVox says, “Healthcare industry is booming and highly focused on patient experience. Here, not so effective call interaction can be a disappointment for the patient. This is often because EHRs and EMRs have always been tough to integrate by contact centers software due to various security concerns as there is patient data. So, our NovelVox team worked hard to embed call controls within Hyperspace. Now the agents can remain on the same environment or screen with added call controls. This empowers agents to reduce call handle time, improve call resolution and enhance caller experience drastically.

About NovelVox

NovelVox is a global software company that has been developing flexible and optimized Contact Center Agent Desktops and Wallboards for Cisco, Avaya, Genesys, and Five9 for over 11 years. NovelVox has an extensive library of over 70 3rd party application integrations. The Novelvox Cisco Finesse Gadget Designer is the world’s only drag and drop Finesse gadget designer, empowering companies to create their perfect agent environments as and when required. With over 150 global deployments across verticals, including banking, telecoms, healthcare, government, education, and retail, NovelVox has the experience to create customized solutions for the healthcare industry.

Share article on social media or email:

KANSAS CITY, Mo. (PRWEB)
April 16, 2020

Today, Caravan Health, announced the initial beta launch of a COVID-19 patient engagement application in one of its rural client sites in California. This is the latest tool helping clinicians deliver virtual care services from the nation’s leader in accountable care and population health programs.

In January of this year, Caravan Health acquired Wellpepper, a Seattle-based technology company, that has developed an award-winning patient engagement platform used across major health systems. As the nation grappled with COVID-19 and new virtual service regulatory changes, Caravan Health accelerated its work with the patient engagement platform to provide its clients with tools to manage and monitor COVID-19-related cases more effectively.

“Our teams have worked diligently to develop and fine tune this patient engagement tool to ensure it is reliable and user-friendly. We believe this innovative technology will help patients stay in touch with their care teams to monitor COVID-like conditions remotely during this public health emergency,” commented Tim Gronniger, CEO and President, Caravan Health.

The application enables clinicians to send a daily, comprehensive account of potential COVID-19 symptoms to their Medicare patients. Patients can self-report their temperature, communicate social determinants of health and request a follow up phone call. Clinicians can track their patient’s reports directly through the application more efficiently without having to wade through excel spreadsheets and individual notes. The technology also helps protect patients and providers from unnecessary risk.

Caravan Health is committed to helping providers and community health systems navigate the COVID-19 public health crisis. Each week, the company hosts free, educational webinars to help clinicians and providers stay informed to the latest information. Topics have included primary care, virtual care best practices and new regulatory changes which are also made available on its COVID-19 Resource page. Please visit caravanhealth.com/covid-19 to learn more.

About Caravan Health:

Caravan Health helps providers make accountable care work regardless of their size, location, history, or demographics. Caravan Health gives community health systems and providers a way to create more scale, drive more change, and generate more revenue. The 250+ health systems who have turned to Caravan achieved single-year savings greatly exceeding the national average. Health systems and providers across the country are using our proven population health programs to ensure better outcomes for their patients every day. With Caravan Health, now the numbers work. For more information visit http://www.caravanhealth.com.

Share article on social media or email:

PHILADELPHIA (PRWEB)
April 16, 2020

Goodway Group, the digital partner advertisers trust to deliver campaign performance and media efficiency, has launched a dashboard to explore COVID-19’s continued impact on the programmatic ecosystem. With marketers rethinking their 2020 plans and forecasts, the dashboard helps give insight into how they should begin pivoting their strategies.

To identify emerging trends and insights, Goodway Group is evaluating data across multiple dimensions, including event-level data from buying platforms and strategic supply-side platform partners. Marketers can use these metrics as a resource to understand the significant impact on the core dynamics of the programmatic marketplace at a national and state level, and better inform their strategies as a result.

As marketers plan for the future, it’s important to analyze regional trends and understand the impact that states are seeing. Current data shows that Pennsylvania and New Jersey have seen a less direct impact on CPMs, in contrast to Washington and California. Some states, including Michigan and Connecticut, have seen later drops in their programmatic auction competition. This resource outlines the importance of zeroing in on the right markets, which is seen in the vast differences state-to-state.

“As consumer behavior shifts and many brands adjust their media strategies in response to the pandemic, marketers need to rethink their strategies based on what’s happening in the United States, down to a regional level,” said Benjamin Diesbach, lead data insights analyst at Goodway Group. “This might not have been considered in the past and is important to factor in future programmatic planning. This is a fluid and dynamic environment, and with CPMs currently going down and inventory going up, they have to look at these trends through a localized lens and evaluate the most up to date information in order to move forward.”

The dashboard features interactive graphs, updated daily, to showcase buy-side prices and competition trends. By analyzing infection rate timing, measured with intrinsic state attributes and overall national trends, Goodway Group is able to further uncover distinct patterns in CPMs. The dashboard also breaks down channel CPMs, highlighting variation across Connected TV (CTV), display and video.

Goodway Group has also released a COVID-19 focused newsletter to share best practices, trends and news. To sign up for this newsletter, visit here.

About Goodway Group:

Goodway Group is the digital partner advertisers trust to drive campaign performance and media efficiency. Proud to be completely independently owned and operated, Goodway provides trustworthy expertise that meets its clients’ needs – and no one else’s. Using predictive intelligence, Goodway helps advertisers get the most value out of every impression across all paid digital media. Through the combination of employing the smartest technology and the most experienced people in the industry, Goodway delivers authentic results. Find Goodway Group online at goodwaygroup.com.

Goodway Group. Honestly Smart Digital.

Share article on social media or email: